Zimmer Biomet Holdings, Inc. (ZBH)
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript
Zimmer (ZBH) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZBH Q1 Earnings & Revenues Top Estimates, Stock Dips in Pre-Market
Zimmer Biomet tops Q1 EPS and revenue estimates with strong segment growth and margin expansion, yet shares slip 1.8% premarket after results.
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.81 per share a year ago.
Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings
ZBH heads into Q1 results with steady EPS estimates, strong knee/hip demand trends and robotics momentum.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Contrasting Zimmer Biomet (NYSE:ZBH) and Capricor Therapeutics (NASDAQ:CAPR)
Capricor Therapeutics (NASDAQ: CAPR - Get Free Report) and Zimmer Biomet (NYSE: ZBH - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership. Profitability This table compares Capricor Therapeutics and Zimmer
Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
